Performance analysis of Pasithea Therapeutics (KTTA)
Annual Return
Over the past 3 years, KTTA has had an average annual return of -66.82%, underperforming the benchmark SPY, which returned +19.62% annual.
Since Sep 15, 2021, KTTA has had an average annual return of -64.71%, underperforming the benchmark SPY, which returned +12.73% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -64.64% | -59.05% | -57.46% | -42.37% | -63.74% | -50.28% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -33.15% | +2.48% | -16.13% | -5.77% | +2.04% | -28.00% | -11.11% | -64.64% | |||||
| 2025 | -28.73% | -48.25% | +12.27% | +27.32% | -41.63% | -25.74% | +0.99% | +11.76% | -9.65% | +10.68% | +80.70% | -12.14% | -59.05% |
| 2024 | -11.45% | +22.17% | -9.43% | -4.52% | -21.09% | -7.30% | +3.66% | -13.30% | +19.09% | -29.96% | -18.57% | +1.84% | -57.46% |
| 2023 | +9.48% | -31.66% | -21.94% | -6.65% | -0% | +39.98% | +22.09% | +1.25% | -20.81% | -27.02% | -6.82% | +13.43% | -42.37% |
| 2022 | -27.11% | -20.94% | +27.47% | -7.69% | -28.54% | +17.77% | +14.84% | -0.86% | +9.57% | -13.48% | -9.18% | -35.17% | -63.74% |
| 2021 | -14.61% | -6.91% | +27.56% | -50.97% | -50.28% |
Drawdown analysis of Pasithea Therapeutics (KTTA)
The maximum drawdown for the KTTA was -99.74%, occurring on Nov 21, 2025. This drawdown has not yet recovered.
The current KTTA drawdown is -99.59%.
Since Sep 15, 2021 KTTA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.74% | Nov 23, 2021 | 1003 | Nov 21, 2025 | Ongoing | Ongoing | Ongoing |
| -37.92% | Sep 15, 2021 | 48 | Nov 22, 2021 | 1 | Nov 23, 2021 | 49 |